Effectiveness and Tolerability of Early Initiation of Combined Lipid -Lowering Therapy Included Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus, Hypertriglyceridemia and Acute Coronary Syndrome
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Aug 2018
Price : $35 *
At a glance
- Drugs Fenofibrate (Primary) ; Simvastatin (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Aug 2016 Planned primary completion date changed from 1 May 2016 to 1 Sep 2016.
- 30 May 2016 Planned End Date changed from 1 Sep 2016 to 1 May 2017.